Efficacy and Tolerance of 4 Weeks of Tedizolid in Prosthetic Joint Infections Treated With Implant Removal

NCT03746327 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Prostheses Infection

Interventions

DRUG: Sivextro 200 milligrams Oral Tablet

Sponsor

Fundacion Clinic per a la Recerca Biomédica